Continuous glucose monitoring (CGM) technology is a powerful tool to identify and correct glycaemic derangements, prevent hypoglycaemia, direct medication management and guide medical nutritional therapy and physical activity recommendations
"Do they cause cancer
(Industry coverage of Eli Lilly's December 2025 TRIUMPH-4 topline announcement, including the 28.7% body weight loss figure on 12mg, the 2.1% placebo figure, and the schedule for remaining 2026 readouts.) Eli Lilly and Company
Medical supervision helps monitor side effects, hydration, nutrition, glucose markers, medications, and treatment tolerance
Which specific compound, and whether it is branded or compounded, is a program-level detail shown during intake
Phase Phase 2 Early maintenance Weeks Weeks 58 Dose 5 mg once weekly Notes First true maintenance dose